Digoxin: The good and the bad
作者： Oliver J. Ziff , Dipak Kotecha
DOI: 10.1016/J.TCM.2016.03.011
关键词:
摘要: … support the use of digoxin in patients with HF due to reduced ejection fraction (HFrEF) [2]. Notably, the Digoxin Investigatorsʼ Group (DIG) trial showed that digoxin improved symptoms …
elsevier.com
tcmonline.org 参考文章(69)
Ingrid Hopper, Marina Skiba, Thomas G. von Lueder, Masataka Watanabe, Robyn Funston, Andrew Tonkin, Henry Krum, Digoxin withdrawal worsens clinical status in stable patients with heart failure receiving optimal contemporaneous therapy--a randomized controlled trial. Journal of Cardiac Failure. ,vol. 21, pp. 779- 781 ,(2015) , 10.1016/J.CARDFAIL.2015.07.003
Larry A. Allen, Gregg C. Fonarow, DaJuanicia N. Simon, Laine E. Thomas, Lucas N. Marzec, Sean D. Pokorney, Bernard J. Gersh, Alan S. Go, Elaine M. Hylek, Peter R. Kowey, Kenneth W. Mahaffey, Paul Chang, Eric D. Peterson, Jonathan P. Piccini, Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort Journal of the American College of Cardiology. ,vol. 65, pp. 2691- 2698 ,(2015) , 10.1016/J.JACC.2015.04.045
Dipak Kotecha, Rajiv Chudasama, Deirdre A. Lane, Paulus Kirchhof, Gregory Y.H. Lip, Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes. International Journal of Cardiology. ,vol. 203, pp. 660- 666 ,(2016) , 10.1016/J.IJCARD.2015.10.220
Pär Hallberg, Johan Lindbäck, Bertil Lindahl, Ulf Stenestrand, Håkan Melhus, , Digoxin and mortality in atrial fibrillation: a prospective cohort study European Journal of Clinical Pharmacology. ,vol. 63, pp. 959- 971 ,(2007) , 10.1007/S00228-007-0346-9
Saif S Rathore, Jeptha P Curtis, Yongfei Wang, Michael R Bristow, Harlan M Krumholz, Association of Serum Digoxin Concentration and Outcomes in Patients With Heart Failure JAMA. ,vol. 289, pp. 871- 878 ,(2003) , 10.1001/JAMA.289.7.871
Kirkwood F. Adams, Mihai Gheorghiade, Barry F. Uretsky, James B. Young, Sagir Ahmed, Lisa Tomasko, Milton Packer, Patients With Mild Heart Failure Worsen During Withdrawal From Digoxin Therapy Journal of the American College of Cardiology. ,vol. 30, pp. 42- 48 ,(1997) , 10.1016/S0735-1097(97)00133-2
James B Young, Mihai Gheorghiade, Barry F Uretsky, J.Herbert Patterson, Kirkwood F Adams, Superiority of “triple” drug therapy in heart failure: insights from the PROVED and RADIANCE trials Journal of the American College of Cardiology. ,vol. 32, pp. 686- 692 ,(1998) , 10.1016/S0735-1097(98)00302-7
M Sonnenblick, A S Abraham, Z Meshulam, U Eylath, Correlation between manifestations of digoxin toxicity and serum digoxin, calcium, potassium, and magnesium concentrations and arterial pH BMJ. ,vol. 286, pp. 1089- 1091 ,(1983) , 10.1136/BMJ.286.6371.1089
Zachary D. Goldberger, G. Caleb Alexander, Digitalis Use in Contemporary Clinical Practice JAMA Internal Medicine. ,vol. 174, pp. 151- 154 ,(2014) , 10.1001/JAMAINTERNMED.2013.10432
Gary R. Matzke, Reginald F. Frye, Drug administration in patients with renal insufficiency : Minimising renal and extrarenal toxicity Drug Safety. ,vol. 16, pp. 205- 231 ,(1997) , 10.2165/00002018-199716030-00005